Medical Instruments & Supplies · Healthcare
Head of Investor Relations
Head of Investor Relations
Bionano Genomics, Inc. (BNGO)Equibles does not estimate personal net worth.
Get an email with a short summary when Bionano Genomics, Inc. publishes a filing, an earnings call transcript or a press release.
Get BNGO alertsWebb Campbell is recorded as Head of Investor Relations at Bionano Genomics, Inc. (BNGO). Webb Campbell has spoken on 3 earnings calls across 1 company, most recently for Bionano Genomics, Inc. on August 10, 2026. Bionano Genomics, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Bionano Genomics, Inc. includes Albert A. Luderer, Ph.D. (CEO and CFO), R. Erik Holmlin (CEO and Board Member), Albert Luderer (Chairman) and 7 others.
“On the call today are Dr. Al Luterer, Chairman and Interim CEO of Bionano, and Mark Adamczak, BioNano's Vice President of Accounting and Principal Accounting Officer.”
“On the call today is Dr. Al Luterer, Chairman and Interim CEO of BioNano, and Mark Adamchak, BioNano's Vice President of Accounting and Principal Accounting Officer.”
“On the call today is Dr. Eric Homlin, CEO and Principal Financial Officer of BioNano, and Mark Adamczyk, BioNano's Vice President of Accounting and Principal Accounting Officer.”
Medical Instruments & Supplies · Healthcare
Head of Investor Relations